ProfileGDS4095 / 220430_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 34% 36% 33% 30% 35% 31% 30% 31% 35% 33% 33% 32% 33% 32% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep12.504834
GSM709769LY2 SRC1-siRNA tamoxifen treated rep32.563836
GSM709765LY2 SRC1-siRNA untreated rep32.4725933
GSM709771LY2 SRC1-siRNA untreated rep12.3510830
GSM709772LY2 SRC1-siRNA untreated rep22.5279835
GSM709775LY2 SRC1-siRNA untreated rep42.402331
GSM709764LY2 control-siRNA tamoxifen treated rep22.3521530
GSM709766LY2 control-siRNA tamoxifen treated rep32.4167831
GSM709768LY2 control-siRNA tamoxifen treated rep12.5303435
GSM709777LY2 control-siRNA tamoxifen treated rep42.4846933
GSM709770LY2 control-siRNA untreated rep32.4410633
GSM709773LY2 control-siRNA untreated rep12.4434132
GSM709774LY2 control-siRNA untreated rep22.4651933
GSM709776LY2 control-siRNA untreated rep42.4437932